Rydex Dyn Inverse NASDAQ-100 2X Strat A
9601 Blackwell Road Suite 500 Rockville MD 20850
Map
Phone: 800-820-0888
| Category: | Bear Market | | Fund Family: | Rydex | | Net Assets: | 1.47M | | Year-to-Date Return: | -59.76% | | Yield: | 1.27% | | Morningstar Rating: | N/A | | Fund Inception Date: | 01-Sep-04 |
|
Michael P. Byrum
Lead Manager since
08-May-06 | | | Byrum is president and CIO of Rydex Investments, his employer since its foundation in 1993. He has ultimate responsibility for the management of the funds. He was named the president of Rydex Investments in 2004 and has served as chief investment officer since 2003.Prior to joining Rydex Investments, Mr. Byrum worked for Money Management Associates, the investment adviser for Rushmore Funds, Inc. Byrum holds the Charted Financial Analyst designation. |
| Min Initial Investment: | $2,500 | | Min Initial Investment, IRA: | $1,000 | | Min Initial Investment, AIP: | NaN | | Min Subsequent Investment: | $0 | | Min Subsequent Investment, IRA: | $0 | | Min Subsequent Investment, AIP: | N/A |
|
| |
| The investment seeks to provide investment results that will match 200% of the performance of the Nasdaq 100 index. The fund invests in leveraged derivative instruments, which primarily consist of equity index swaps, futures contracts, and options on securities, futures contracts, and stock indices.It will invest at least 80% of net assets in financial instruments with economic characteristics that should perform opposite to the securities of companies included in the underlying index.It is a nondiversified enhanced index . |
| Last Dividend
(8-Dec-08):
| 0.11 | | Last Cap Gain
| YFT_NOT_APPLICABLE_ABBREVIATION | | Annual Holdings Turnover
| YFT_NOT_APPLICABLE_ABBREVIATION | | Average for Category:
| 364.34% |
|
| Expense | RYVTX | Category
Avg | | Total Expense Ratio: | 1.76%
| 1.93% | | Max 12b1 Fee: | 0.25%
| N/A | | Max Front End Sales Load: | 4.75%
| 4.81% | | Max Deferred Sales Load: | %
| 1.21% | | 3 Yr Expense Projection*: |
$ 1,003 | $783 | | 5 Yr Expense Projection*: |
$ 1,384 | $1,270 | | 10 Yr Expense Projection*: |
$ 2,450 | $2,623 |
|
|
0.17% Nasdaq 0.00%
0.10 (1.15%) 
Profile
